Structural mapping and network analysis of patient-specific mutations in glioblastoma

Kaya, Tuğba
Cancer is one of the most common cause of death worldwide. It occurs as a result of a collection of somatic deviations from normal state. Therefore, many efforts have been invested to profile mutations in different types of tumors; such as, the Cancer Genome Atlas (TCGA) which deposits multiple omic data for more than 11,000 tumor samples. In this thesis, we present a pipeline which retrieves patient-specific mutation data in Glioblastoma from TCGA, maps these mutations on the protein structures in Protein Databank (PDB) and finds the location and functional effect of the mutations and reconstruct functional networks by integrating mutation data with interactome. As a result of this thesis study, we found that some mutations are specific to alternative isoform sequence of the protein instead of the canonical sequence. We also showed that functional impact of mutations in interface region is more damaging compared to the surface region and more similar to the core region of the protein. We showed that most common change in the protein core is that hydrophobic residues are mutated to another hydrophobic residue. However, in the surface or interface region a charged residue is changed either to another charged residue or a polar residue when we analyzed the chemical classes of mutations. From these mutation profiles of the patients, we reconstructed 290 GBM-specific networks with Omics Integrator which solves the prize-collecting Steiner forest (PCSF) problem and optimally connects the given set of proteins in a network context. We merged the most common nodes and edges across these patients and clustered the merged network into functional communities. The ontology and pathway enrichment analyses gave us that Wnt signaling, ERBB signaling and NfKb/Ikb signaling pathways are the most commonly enriched pathways. From mutation to protein structures and functional networks, we believe that the result of this thesis will have significant contribution in cancer research.


The Mechanism of anti tumorigenic effects of 15-lox-1 in colon cancer
Çimen, İsmail; Banerjee, Sreeparna; Department of Biology (2012)
Colorectal cancer is the 4th most widespread cause of cancer mortality. One of the pathways that are involved in the development of colorectal cancer is the arachidonic acid metabolizing lipoxygenase (LOX) pathway. Inflammatory molecules formed from this pathway exert profound effects that may exacerbate the development and progression of colon and other cancers. 15 lipoxygenase-1 (15-LOX-1) is a member of LOX protein family that metabolizes primarily linoleic acid to 13-(S)-HODE. Several lines of evidence ...
Analyses and modeling of ovarian cancer microarray data
Karakelle, Barış S; Purutçuoğlu Gazi, Vilda; Department of Biomedical Engineering (2019)
Ovarian cancer is one of the common cancer types among other oncological diseases. The major causes of this cancer can be listed as age, obesity, hormone therapy, material inheritance and contraceptive pills. Due to its generality and importance, many researches have been conducted from distinct labs about this illness and its plausible causes have been intensively investigated either inmicroarray studies, where just part of the related genes are detected, or in thepairwise correlation analyses between the ...
Synthesis and biological evaluation of novel pyrazolic chalcone derivatives as novel hepatocellular carcinoma therapeutics.
Hawash, Mohammed M. A.; Kahraman, Deniz Cansen; Eren, Fikriye; Atalay, Rengül; BAYTAŞ, Sultan (2017-03-31)
Despite having the second highest mortality associated with cancer, currently Sorafenib is the only FDA-approved chemotherapeutic agent available for liver cancer patients which can only improve survival for few months. In this study, various pyrazolic chalcone analogous compounds were synthesized and evaluated as potential chemotherapeutic agents for the treatment of hepatocellular carcinoma (HCC). Modifying the central pyrazole ring at the C(3)-position with different heteroaryl rings and substituting the...
Investigaton of chemopreventive properties of Urtica Dioica L., in MCF-7 and MDA231 breast cancer cell lines
Güler, Elif; İşcan, Mesude; Department of Biology (2011)
Cancer is a major health problem in developing world with mostly unsufficient treatment. Cancer prevention through dietary modification appears to be a practical and cost effective possibility. The aim of present study is to investigate the chemical components of “Urtica diocia,L (U. diocia) grown in Turkey” and the possible protective potential of its aqueous extract against breast cancer cell lines. U. diocia was extracted by maceration method which was performed for 6,12, 24, and 36 hours, at 50°C, 37°C,...
Network-based discovery of molecular targeted agent treatments in hepatocellular carcinoma
Fayetörbay, Rumeys; Tunçbağ, Nurcan; Department of Bioinformatics (2020)
Hepatocellular carcinoma (HCC) is one of the most-deadly cancers and the most common type of primary liver cancer. Multikinase inhibitor Sorafenib is one of FDA approved targeted agents in HCC treatment. PI3K/AKT/mTOR pathway is altered in about 51% of HCC; hence, understanding how Sorafenib and PI3K/AKT/mTOR pathway inhibitors act at signaling level is crucial for targeted therapies and to reveal the off-target effects. In this work, we use gene expression profiles (GEPs) of HCC cells (Huh7 and Mahlavu) wh...
Citation Formats
T. Kaya, “Structural mapping and network analysis of patient-specific mutations in glioblastoma,” M.S. - Master of Science, Middle East Technical University, 2018.